Helicobacter pylori: The place of the new macrolides in the eardication of the bacteria in peptic ulcer disease
- 1 January 1995
- journal article
- review article
- Published by Springer Nature in Infection
- Vol. 23 (1), S44-S52
- https://doi.org/10.1007/bf02464960
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- In vitro susceptibility testing of Helicobacter pylori to antimicrobial Agents: Basis for treatment or microbiologists' obsession?Zentralblatt für Bakteriologie, 1993
- Effect of pH variation on the susceptibility ofHelicobacter pylori to three macrolide antimicrobial agents and temafloxacinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- Eradication ofHelicobacter pylori: therapies and clinical implicationsPostgraduate Medical Journal, 1992
- Helicobacter pylori infection and duodenal ulcer diseaseJournal of Internal Medicine, 1992
- Activity of lansoprazole against Helicobacter pyloriThe Lancet, 1991
- Duodenal ulcer: the villain unmasked?BMJ, 1991
- Antibacterial activity of pantoprazole and omeprazole againstHelicobacter pyloriEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Effect of varying pH on the susceptibility ofCampylobacter pylori to antimicrobial agentsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Campylobacter Pylori and Non-Ulcer Dyspepsia: 2. A Prospective Study in a Swedish PopulationScandinavian Journal of Gastroenterology, 1989
- Campylobacter Pylori and Gastroduodenal Ulcer Disease: A Prospective Study in a Swedish PopulationScandinavian Journal of Gastroenterology, 1989